niacinamide
Small moleculeexperimental
Clinical trial activity
13 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
4
Earliest trial started Aug 31, 2006 (NCT01892423)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Poly [ADP-ribose] polymerase 10INHIBITOR
PARP10 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06015217 | Phase 4 | Aug 25, 2023 | Galderma |
| NCT05530707 | N/A | Sep 5, 2022 | Farmoquimica S.A., Medcin Instituto da Pele |
| NCT05686928 | Phase 4 | Aug 17, 2022 | Galderma |
| NCT03188653 | N/A | May 31, 2017 | University of Arizona |
| NCT02589392 | Phase 4 | May 31, 2015 | Galderma |
| NCT02216526 | N/A | Sep 30, 2014 | Humboldt University |
| NCT01885130 | N/A | Dec 31, 2012 | AMA Laboratories Inc., Galderma |
| NCT01887808 | N/A | Dec 31, 2012 | AMA Laboratories Inc., Galderma |
| NCT01887860 | N/A | Dec 31, 2012 | AMA Laboratories Inc., Galderma |
| NCT01892410 | N/A | Dec 31, 2012 | AMA Laboratories Inc., Galderma |
| NCT01375205 | N/A | Jun 30, 2011 | Galderma, Oregon Health and Science University |
| NCT01063218 | Phase 4 | Dec 31, 2009 | Galderma |
| NCT01892423 | N/A | Aug 31, 2006 | Galderma |
Showing 13 of 13 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Galderma | For profit | 10 | 9 | 2 | 2006 |
| AMA Laboratories Inc. | For profit | 4 | 0 | 1 | 2012 |
| Farmoquimica S.A. | For profit | 1 | 1 | 1 | 2022 |
| Humboldt University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Medcin Instituto da Pele | Academic/Hospital | 1 | 0 | 1 | 2022 |
| Oregon Health and Science University | Academic/Hospital | 1 | 1 | 1 | 2011 |
| University of Arizona | Academic/Hospital | 1 | 1 | 1 | 2017 |
7 organizations
Page 1 / 1